Further, the patient’s age, FIGO staging, and BTG3 protein expression (p < 0.05) but not pathological classification, differentiation residual lesion size, or serum CA125 level were independent prognostic factors for disease-free ovarian carcinomas (p > 0.05, Table 4). This evidence concerns the gene BTG3 and ovarian carcinoma.